Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Mononuclear Cells for Alzheimer's Disease
NCT07208344Phase 1Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of umbilical cord blood mononuclear cells in Alzheimer's disease (AD) (3 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoints: Clinical Dementia Rating Scale-Sum of Boxes at 6 months and Activity of Daily Living Scale at 6 months. Started Jul 2025; status: recruiting.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07208344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07208344.